Webster AC et al. |
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. |
2005 |
BMJ |
pmid:16157605
|
Iheanacho I |
Definitely not acceptable: drug company sues journal over review. |
2011 |
BMJ |
pmid:21285186
|
Brousse N and Goulet O |
Small bowel transplantation. |
1996 |
BMJ |
pmid:8611766
|
Misra DP et al. |
Pulmonary co-infection with Nocardia and Aspergillus in a patient with adult-onset Still's disease receiving steroids and tacrolimus. |
2014 |
BMJ Case Rep |
pmid:25398925
|
Slocum AMY |
A surgeon's nightmare: pyoderma gangrenosum with pathergy effect mimicking necrotising fasciitis. |
2017 |
BMJ Case Rep |
pmid:29269363
|
Maus EA |
The importance of challenging your diagnosis even in straightforward cases. |
2012 |
BMJ Case Rep |
pmid:22847565
|
Mallon DH et al. |
A spontaneous coronary arterial dissection associated with a calcineurin inhibitor. |
2012 |
BMJ Case Rep |
pmid:22783013
|
Borges-Costa J et al. |
Kaposi's sarcoma presenting as violaceous macules on the chest of a kidney transplanted patient. |
2016 |
BMJ Case Rep |
pmid:26759393
|
Bonanni A et al. |
Low-dose ofatumumab for rituximab-resistant nephrotic syndrome. |
2015 |
BMJ Case Rep |
pmid:26376698
|
Wu G et al. |
Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. |
2013 |
BMJ Case Rep |
pmid:24311415
|
Purani JM and Purani HJ |
Treatment of geographic tongue with topical tacrolimus. |
2014 |
BMJ Case Rep |
pmid:25085945
|
Viecelli A et al. |
Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia. |
2014 |
BMJ Case Rep |
pmid:25257886
|
Kirpalani A et al. |
Idiosyncratic drug reactions and membranous glomerulopathy. |
2017 |
BMJ Case Rep |
pmid:28137906
|
Liu HY et al. |
Ribavirin-induced anaemia reduced tacrolimus level in a hepatitis C patient receiving haemodialysis. |
2018 |
BMJ Case Rep |
pmid:29669765
|
Gupta M et al. |
Tacrolimus-induced unilateral ischaemic optic neuropathy in a non-transplant patient. |
2012 |
BMJ Case Rep |
pmid:22914240
|
Krystel-Whittemore M et al. |
Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis. |
2015 |
BMJ Case Rep |
pmid:26318171
|
Boyer NL et al. |
Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient. |
2013 |
BMJ Case Rep |
pmid:23396921
|
Undre N and Dickinson J |
Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants. |
2017 |
BMJ Open |
pmid:28377389
|
Goldsmith PM et al. |
Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol. |
2017 |
BMJ Open |
pmid:28756385
|
Castillo Lugo JA |
Clinical and experimental immunosuppression. |
1995 May-Jun |
Bol Asoc Med P R |
pmid:8573248
|
Varanasi SS and Datta HK |
Characterisation of cytosolic FK506 binding protein 12 and its role in modulating expression of Cbfa1 and osterix in ROS 17/2.8 cells. |
2005 |
Bone |
pmid:15780950
|
Fukunaga J et al. |
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. |
2004 |
Bone |
pmid:15003790
|
Darcy A et al. |
A novel library screen identifies immunosuppressors that promote osteoblast differentiation. |
2012 |
Bone |
pmid:22421346
|
Voggenreiter G et al. |
Immunosuppression with FK506 has no influence on fracture healing in the rat. |
2005 |
Bone |
pmid:15963777
|
Igarashi K et al. |
Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. |
2004 |
Bone |
pmid:15207740
|
Velasco-Guardado A et al. |
Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD. |
2016 |
Bone Marrow Transplant. |
pmid:26950379
|
Parody R et al. |
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study. |
2016 |
Bone Marrow Transplant. |
pmid:27295268
|
Hale GA et al. |
Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. |
2000 |
Bone Marrow Transplant. |
pmid:10723590
|
Rotenstein L et al. |
Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation. |
2016 |
Bone Marrow Transplant. |
pmid:27272445
|
Schmook T et al. |
Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus. |
2005 |
Bone Marrow Transplant. |
pmid:15895116
|
Boswell GW et al. |
Tacrolimus pharmacokinetics in BMT patients. |
1998 |
Bone Marrow Transplant. |
pmid:9486490
|
Tezcan H et al. |
Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506. |
1998 |
Bone Marrow Transplant. |
pmid:9486505
|
Ali H et al. |
Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus. |
2015 |
Bone Marrow Transplant. |
pmid:25365064
|
Labrador J et al. |
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. |
2014 |
Bone Marrow Transplant. |
pmid:24566710
|
Gharpure VS et al. |
Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:8547871
|
Wingard JR et al. |
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients. |
1997 |
Bone Marrow Transplant. |
pmid:9232256
|
Jacobson P et al. |
Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients. |
2001 |
Bone Marrow Transplant. |
pmid:11781626
|
Menillo SA et al. |
Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation. |
2001 |
Bone Marrow Transplant. |
pmid:11781637
|
Mori T et al. |
Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. |
2009 |
Bone Marrow Transplant. |
pmid:19270729
|
Misawa A et al. |
FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. |
2000 |
Bone Marrow Transplant. |
pmid:10673708
|
Przepiorka D et al. |
Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10414918
|
Okano A et al. |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation. |
2001 |
Bone Marrow Transplant. |
pmid:11704796
|
Parody R et al. |
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT. |
2015 |
Bone Marrow Transplant. |
pmid:25310306
|
Takahata M et al. |
Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus. |
2001 |
Bone Marrow Transplant. |
pmid:11704797
|
Espino G et al. |
Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD. |
2001 |
Bone Marrow Transplant. |
pmid:11803349
|
Watanabe N et al. |
Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children. |
2010 |
Bone Marrow Transplant. |
pmid:19915626
|
Uberti JP et al. |
Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies. |
1997 |
Bone Marrow Transplant. |
pmid:9208118
|
Ohashi Y et al. |
Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506. |
1997 |
Bone Marrow Transplant. |
pmid:9085743
|
Kato H et al. |
Significant improvement of Takayasu arteritis after cord blood transplantation in a patient with myelodysplastic syndrome. |
2014 |
Bone Marrow Transplant. |
pmid:24317130
|
Takamatsu Y et al. |
Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. |
2001 |
Bone Marrow Transplant. |
pmid:11571519
|
Przepiorka D et al. |
Practical considerations in the use of tacrolimus for allogeneic marrow transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10578154
|
Furlong T et al. |
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. |
2000 |
Bone Marrow Transplant. |
pmid:11100278
|
Narimatsu H et al. |
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. |
2007 |
Bone Marrow Transplant. |
pmid:17115066
|
Lekakis L et al. |
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. |
2006 |
Bone Marrow Transplant. |
pmid:16892072
|
Ikegame K et al. |
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin. |
2003 |
Bone Marrow Transplant. |
pmid:12796797
|
Przepiorka D et al. |
Tacrolimus clearance is age-dependent within the pediatric population. |
2000 |
Bone Marrow Transplant. |
pmid:11041564
|
Ganetsky A et al. |
Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation. |
2016 |
Bone Marrow Transplant. |
pmid:26691423
|
Woo M et al. |
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. |
1997 |
Bone Marrow Transplant. |
pmid:9466284
|
Jabbour E et al. |
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. |
2007 |
Bone Marrow Transplant. |
pmid:17603511
|
Honda A et al. |
Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT. |
2013 |
Bone Marrow Transplant. |
pmid:22751000
|
Ram R et al. |
Prophylaxis regimens for GVHD: systematic review and meta-analysis. |
2009 |
Bone Marrow Transplant. |
pmid:18997826
|
Neuman DL et al. |
Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease. |
2005 |
Bone Marrow Transplant. |
pmid:16151424
|
Messina C et al. |
Prevention and treatment of acute GvHD. |
2008 |
Bone Marrow Transplant. |
pmid:18545247
|
Khimani F et al. |
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention. |
2017 |
Bone Marrow Transplant. |
pmid:28368376
|
Skeens M et al. |
Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation. |
2012 |
Bone Marrow Transplant. |
pmid:22484323
|
Hiraoka A et al. |
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. |
2001 |
Bone Marrow Transplant. |
pmid:11509936
|
Yu C et al. |
Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation. |
1997 |
Bone Marrow Transplant. |
pmid:9244417
|
Yoshida Y et al. |
FK506-associated limbic injury following umbilical cord blood transplantation. |
2003 |
Bone Marrow Transplant. |
pmid:12942100
|
Gaziev D et al. |
Chronic graft-versus-host disease: is there an alternative to the conventional treatment? |
2000 |
Bone Marrow Transplant. |
pmid:10745252
|
Mori T et al. |
Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients. |
2011 |
Bone Marrow Transplant. |
pmid:20453893
|
Eagle DA et al. |
Gastroparesis following bone marrow transplantation. |
2001 |
Bone Marrow Transplant. |
pmid:11498745
|
Seropian S et al. |
Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma. |
2003 |
Bone Marrow Transplant. |
pmid:14520419
|
Kanamaru A et al. |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. |
1995 |
Bone Marrow Transplant. |
pmid:7581086
|
Koehler MT et al. |
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:7581088
|
Hsiao CC et al. |
Evaluation for synergistic suppression of T cell responses to minor histocompatibility antigens by chloroquine in combination with tacrolimus and a rapamycin derivative, SDZ-RAD. |
2002 |
Bone Marrow Transplant. |
pmid:12476284
|
Najera JE et al. |
Akinetic mutism-a serious complication to tacrolimus-based GVHD prophylaxis. |
2013 |
Bone Marrow Transplant. |
pmid:22705799
|
Devine SM et al. |
Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation. |
1996 |
Bone Marrow Transplant. |
pmid:8879619
|
Przepiorka D et al. |
Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. |
1993 |
Bone Marrow Transplant. |
pmid:7687503
|
Trifilio SM et al. |
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring. |
2010 |
Bone Marrow Transplant. |
pmid:19966844
|
Ochiai N et al. |
Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. |
2002 |
Bone Marrow Transplant. |
pmid:12439703
|
Yu C et al. |
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. |
1996 |
Bone Marrow Transplant. |
pmid:8722370
|
Mori T et al. |
Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation. |
2005 |
Bone Marrow Transplant. |
pmid:15937504
|
Suehiro A et al. |
Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation. |
2002 |
Bone Marrow Transplant. |
pmid:11850703
|
Uberti JP et al. |
Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes. |
2004 |
Bone Marrow Transplant. |
pmid:15273705
|
Nelson R et al. |
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience. |
2015 |
Bone Marrow Transplant. |
pmid:26301969
|
Elefante A et al. |
Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels. |
2006 |
Bone Marrow Transplant. |
pmid:16518428
|
Sastry J et al. |
Acute pancreatitis due to tacrolimus in a case of allogeneic bone marrow transplantation. |
2004 |
Bone Marrow Transplant. |
pmid:14743193
|
Han CW et al. |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. |
1995 |
Bone Marrow Transplant. |
pmid:7545487
|
Castagna L et al. |
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide. |
2016 |
Bone Marrow Transplant. |
pmid:26595078
|
Mookerjee B et al. |
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. |
1999 |
Bone Marrow Transplant. |
pmid:10482936
|
Terakura S et al. |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil. |
2017 |
Bone Marrow Transplant. |
pmid:27941766
|
Yanagisawa R et al. |
Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT. |
2011 |
Bone Marrow Transplant. |
pmid:20383212
|
Zohren F et al. |
Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases. |
2011 |
Bone Marrow Transplant. |
pmid:20661230
|
Perez LE et al. |
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. |
2017 |
Bone Marrow Transplant. |
pmid:27991896
|
Trede NS et al. |
Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. |
1997 |
Bone Marrow Transplant. |
pmid:9257897
|
Khaled SK et al. |
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. |
2013 |
Bone Marrow Transplant. |
pmid:23000644
|
Nieto Y et al. |
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. |
2000 |
Bone Marrow Transplant. |
pmid:10918414
|
Yanik G et al. |
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. |
2000 |
Bone Marrow Transplant. |
pmid:10918426
|
Mawardi H et al. |
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD. |
2010 |
Bone Marrow Transplant. |
pmid:19881552
|
Kanda J et al. |
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. |
2013 |
Bone Marrow Transplant. |
pmid:23334274
|